The global fetal bovine serum market was valued at USD 1.7 billion in 2022, growing at a CAGR of 13.6% from 2023 to 2032. The market is expected to reach USD 6.0 billion by 2032. During the forecast period, it is anticipated that factors, including the growth of the biopharmaceutical sector in both developed and emerging nations, will increase demand for foetal bovine serum (FBS).
When pregnant cows are processed, the foetal blood of the foetuses from those cows is used to create foetal bovine serum (FBS), a nutrient-rich combination. It is a frequently used addition in cell culture media to promote the proliferation and viability of several cell types, such as primary cells, mammalian cells, and stem cells. Because of its superior growth qualities, FBS facilitates drug discovery, manufacture, and development. Cell attachment uses it as a buffer against external disturbances such as pH shifts and endotoxins. By including FBS in the freezing media, oxidative damage is avoided. Gene and cell therapies share many manufacturing techniques, which raises the risk of a potential conflict in the raw material supply chain with the production of recombinant vaccines. In addition to limited antibodies, trace elements, proteins, vitamins, growth factors, attachment factors, and hormones, it offers sheer protective power. Owing to the high concentration of elements that promote embryonic growth, foetal bovine serum is also utilized as an extra media supplement for cell culture. The serum is thought to be among the best growth promoters available for the majority of cell culture methods when compared to other animal-based serums.
Get an overview of this study by requesting a free sample
In April 2021, A definitive deal between Thermo Fisher Scientific Inc. and PPD Inc. was announced, wherein Thermo Fisher will purchase PPD for a sum of USD 17.4 billion.
In March 2021, Merck KgAA declared that it will invest EUR 25 million to expand a production line for single-use assemblies at its Life Science Centre located in Molsheim, France.
Growing market participants' investments in the life science industry- The market for foetal bovine serum is being driven by a surge in research and development efforts within the life science sector. Regenerative medicine is a new area in the life science industry that deals with replacing, repairing, or growing damaged tissues or organs. In tissue engineering and cell-based therapy, two important fields of regenerative medicine research, foetal bovine serum is frequently employed. The need for FBS as a crucial component of these therapies rises as market participants invest more in regenerative medicine research and clinical trials. This drives the FBS market and increases venture capital investment, a strong workforce, the rapid expansion of the pharmaceutical industries, and government initiatives to support life science research.
Increasing price- It has been acknowledged that using cattle to produce Fetal Bovine Serum (FBS) has increased the price of FBS on the market. An increasing number of calves are being killed for making FBS, which is illegal in the according to PETA, and the producers face steep fines that drive down their marketable output. The significant spike in demand for FBS and the decline in production are the reasons for this price increase, which is hindering the market’s growth.
Increasing demand for FBS as a result of the shortage- Compared to other growth supplements, FBS is reasonably priced and easily obtainable from commercial vendors. Prices may rise if there is a greater demand for FBS than there is supply. FBS manufacturers and suppliers now have the chance to take advantage of the pricing difference and increase sales and earnings. To satisfy the rising demand and benefit from advantageous market conditions, producers are also investing in increasing their production capacity, which is expected to provide growth opportunities for the market during the forecast period.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global fetal bovine serum market, with a 37.8% market revenue share in 2022.
One of the main reasons for the market's expansion in the North American region is the rise in R&D spending by government organizations. The world's strongest R&D ecosystem is thought to exist in the United States. For example, a July 2022 news report states that the biotechnology sector increased its R&D spending by 94% between 2016 and 2021, reaching a total of USD 88.6 billion. The development of biopharmaceutical goods, the existence of well-established competitors in the region, and a robust healthcare infrastructure are further factors contributing to the market's growth in the region.
North America Region Fetal Bovine Serum Market Share in 2022 - 37.8%
Check the geographical analysis of this market by requesting a free sample
The application segment is divided into vaccine production, drug discovery, in-vitro fertilization, cell-based research, diagnostics, toxicity testing, and cell therapy. The vaccine production segment dominated the market, with a market share of around 25% in 2022. Due to the increased manufacturing of the innovative vaccine, the segment has been expanding. FBS is a rich supply of nutrients, hormones, and growth factors that are necessary for cell growth and proliferation.
The end-user segment is divided into pharmaceutical and biotechnology industries, diagnostic labs, research labs, IVF centres, and academic institutes. The pharmaceuticals and biotechnology industries segment dominated the market, with a market share of around 32% in 2022. A greater number of pharmaceutical and biotechnology companies have grown as a result of the rise in populations with diabetes and hypertension worldwide. These industries provide medications for the diseases mentioned above, which helps them earn the largest revenue share from foetal bovine serum and achieve maximum growth.
|Market Size||Revenue (USD Billion)|
|Market size value in 2022||USD 1.7 Billion|
|Market size value in 2032||USD 6.0 Billion|
|CAGR (2023 to 2032)||13.6%|
|Region||The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.|
As per The Brainy Insights, the size of the fetal bovine serum market was valued at USD 1.7 billion in 2022 to USD 6.0 billion by 2032.
The global fetal bovine serum market is growing at a CAGR of 13.6% during the forecast period 2023-2032.
North America emerged as the largest fetal bovine serum market.
Key players in the fetal bovine serum market are Thermo Fisher Scientific Inc., Rocky Mountain Biologicals, Sartorius, Bio-Techne, Merck KGaA, Danaher, HiMedia Laboratories Pvt. Ltd, Sera Scandia, Atlas Biologicals, and PAN-Biotech.
This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global fetal bovine serum market based on the below-mentioned segments:
Global Fetal Bovine Serum Market By Application:
Global Fetal Bovine Serum Market By End-User:
Global Fetal Bovine Serum Market By Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date